These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 4367422)

  • 1. Activity of inactivated Burcella on murine tumors: prophylactic effects and combination with specific immunostimulation.
    Le Garrec Y; Sabolovic D; Toujas L; Dazord L; Guelfi J; Pilet C
    Biomedicine; 1974 Jan; 21(1):40-3. PubMed ID: 4367422
    [No Abstract]   [Full Text] [Related]  

  • 2. Virus-chemical carcinogenesis: a possible viral immunologic influence on 3-methylcholanthrene sarcoma induction.
    Whitmire CE
    J Natl Cancer Inst; 1973 Aug; 51(2):473-8. PubMed ID: 4358133
    [No Abstract]   [Full Text] [Related]  

  • 3. [Antigenic systems of tumors and leukemias induced by oncornaviruses].
    Levy JP; Kourilsky FM
    Ann Inst Pasteur (Paris); 1972 Apr; 122(4):741-53. PubMed ID: 4340545
    [No Abstract]   [Full Text] [Related]  

  • 4. [Immunologic characterization of sarcomas artificially infected with Graffi leukemia virus. II. Studies on the differentiation between viral and new cellular antigens].
    Pasternak L; Pasternak G
    Arch Geschwulstforsch; 1968; 32(4):301-8. PubMed ID: 4308111
    [No Abstract]   [Full Text] [Related]  

  • 5. The G (Gross) leukemia antigen.
    Old LJ; Boyse EA; Stockert E
    Cancer Res; 1965 Jul; 25(6):813-9. PubMed ID: 4284252
    [No Abstract]   [Full Text] [Related]  

  • 6. [Brucella and modification of the host response to bacterial and viral infection. Effect of the S-R variation].
    Pilet C; Le Garrec Y
    Dev Biol Stand; 1976; 31():61, 399-407. PubMed ID: 816692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy of a murine leukemia virus-infected, chemically induced murine sarcoma with antiviral antibodies.
    Ward EC; Iglehart JD; Weinhold KJ; Bolognesi DP
    J Natl Cancer Inst; 1982 Aug; 69(2):509-15. PubMed ID: 6955550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoprophylaxis of transplantable methylcholanthrene-induced murine fibrosarcomas by immunization with embryo cells expressing endogenous murine leukemia virus antigens.
    Zbar B; Manohar V; Sugimoto T; Ashley MP; Kato Y; Rappaport P
    Cancer Res; 1981 Nov; 41(11 Pt 1):4499-507. PubMed ID: 6272979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo antigenic modification of tumor cells. I. Introduction of murine leukemia virus antigens on non-virus-producing murine sarcomas.
    Iglehart JD; Ward EC; Thiel K; Huper G; Geier SS; Bolognesi DP
    J Natl Cancer Inst; 1981 Jul; 67(1):107-15. PubMed ID: 6942181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T cell tolerance in moloney-murine leukemia virus (M-MuLV) carrier mice: low cytotoxic T lymphocyte precursor frequency and absence of suppressor T cells in carrier mice with Moloney-murine sarcoma (M-MSV)-induced tumors.
    Collavo D; Ronchese F; Zanovello P; Biasi G; Chieco-Bianchi L
    J Immunol; 1982 Feb; 128(2):774-9. PubMed ID: 6459385
    [No Abstract]   [Full Text] [Related]  

  • 11. Thymocytolytic autoantibodies elicited by immunization of mice with chemically-induced sarcoma and leukemia cells.
    Merino F
    Acta Cient Venez; 1982; 33(5):402-5. PubMed ID: 6985343
    [No Abstract]   [Full Text] [Related]  

  • 12. Antigenic relationship between SL-leukemia cells and other murine leukemia cells.
    Ishimoto A
    Gan; 1969 Aug; 60(4):355-66. PubMed ID: 4310634
    [No Abstract]   [Full Text] [Related]  

  • 13. Protective effects of orchidectomy on tumour induction and transplantation in mice.
    Castro JE
    Br J Surg; 1972 Nov; 59(11):904. PubMed ID: 4637109
    [No Abstract]   [Full Text] [Related]  

  • 14. [Antigenicity of xenogenized tumor cells with special reference to amounts of virus-associated antigen (author's transl)].
    Yamaguchi H
    Hokkaido Igaku Zasshi; 1981 Jul; 56(4):439-48. PubMed ID: 7327520
    [No Abstract]   [Full Text] [Related]  

  • 15. [Detection of the cytotoxic effect of tumor cells against the targets of normal killers].
    Fuks BB; Zedginidze MS; Spirande IV; Kogarko IN; Sterlina AG
    Biull Eksp Biol Med; 1981 Sep; 92(9):342-5. PubMed ID: 7295991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotherapy of a carcinogen-induced murine sarcoma with soluble tumor-specific transplantation antigens.
    Kahan BD; Tanaka T; Pellis NR
    J Natl Cancer Inst; 1980 Nov; 65(5):1001-4. PubMed ID: 6159495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunologic unresponsiveness to murine leukemia virus antigens: mechanisms and role in tumor development.
    Chieco-Bianchi L; Collavo D; Biasi G
    Adv Cancer Res; 1988; 51():277-306. PubMed ID: 2851924
    [No Abstract]   [Full Text] [Related]  

  • 18. Antibodies to murine leukemia virus gp70 and p15(E) in sera of BALB/c mice immunized with syngeneic chemically induced sarcomas.
    Klitzman JM; Brown JP; Hellström KE; Hellström I
    J Immunol; 1980 Jun; 124(6):2552-6. PubMed ID: 6246166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased tumorigenesis of murine sarcoma virus (Moloney) by coinfection with Rauscher virus or by treatment with antilymphocyte serum.
    Hook WA; Chirigos MA; Chan SP
    Cancer Res; 1969 May; 29(5):1008-12. PubMed ID: 5781092
    [No Abstract]   [Full Text] [Related]  

  • 20. [Humoral immunity in viral reticulosarcomatosis in mice].
    Bergol'ts VM; Moskovkina OIa; Sokolov PP; Sukhin GM; Kondrat'eva IA
    Vopr Onkol; 1974; 20(11):35-9. PubMed ID: 4373907
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.